Pharmaceutical Compositions Comprising An S1P Modulator

Patent No. EP3103448 (titled "Pharmaceutical Compositions Comprising An S1P Modulator") was filed by Novartis on Sep 25, 2007. The application was issued on Jul 3, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3103448

NOVARTIS
Application Number
EP16176663A
Filing Date
Sep 25, 2007
Status
Granted And Under Opposition
May 31, 2019
Publication Date
Jul 3, 2019